[go: up one dir, main page]

ES2159491B1 - Base cristalina de citalopram - Google Patents

Base cristalina de citalopram

Info

Publication number
ES2159491B1
ES2159491B1 ES200100548A ES200100548A ES2159491B1 ES 2159491 B1 ES2159491 B1 ES 2159491B1 ES 200100548 A ES200100548 A ES 200100548A ES 200100548 A ES200100548 A ES 200100548A ES 2159491 B1 ES2159491 B1 ES 2159491B1
Authority
ES
Spain
Prior art keywords
citalopram
crystal base
salts
base
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200100548A
Other languages
English (en)
Other versions
ES2159491A1 (es
Inventor
Hans Petersen
Klaus Peter Boegesoe
Per Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2159491(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of ES2159491A1 publication Critical patent/ES2159491A1/es
Application granted granted Critical
Publication of ES2159491B1 publication Critical patent/ES2159491B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Laminated Bodies (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

Base cristalina de citalopram, 1-[3-dimetilamino)propil]-1-(4- fluoro-fenil)-1,3-dihidro-5-isobenzofurano-carbonitrilo, un bien conocido fármaco antidepresivo, formulaciones de dicha fase, un procedimiento para la preparación de sales purificadas de citalopram, tales como el hidrobromuro, por uso de la base, las sales obtenidas por dicho procedimiento y formulaciones que contienen dichas sales.
ES200100548A 2000-03-13 2001-03-09 Base cristalina de citalopram Expired - Fee Related ES2159491B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13

Publications (2)

Publication Number Publication Date
ES2159491A1 ES2159491A1 (es) 2001-10-01
ES2159491B1 true ES2159491B1 (es) 2002-05-01

Family

ID=8159320

Family Applications (3)

Application Number Title Priority Date Filing Date
ES02009350T Expired - Lifetime ES2180471T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram y su sal hidrocloruro o hidrobromuro.
ES01909568T Expired - Lifetime ES2173054T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram.
ES200100548A Expired - Fee Related ES2159491B1 (es) 2000-03-13 2001-03-09 Base cristalina de citalopram

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES02009350T Expired - Lifetime ES2180471T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram y su sal hidrocloruro o hidrobromuro.
ES01909568T Expired - Lifetime ES2173054T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram.

Country Status (41)

Country Link
US (7) US20010031784A1 (es)
EP (2) EP1227088B1 (es)
JP (1) JP2003527383A (es)
KR (1) KR20020080486A (es)
CN (2) CN1258530C (es)
AR (1) AR029811A1 (es)
AT (3) ATE250050T1 (es)
AU (2) AU746664B2 (es)
BE (1) BE1013210A3 (es)
BG (1) BG107065A (es)
BR (1) BR0109373A (es)
CA (2) CA2411732A1 (es)
CH (2) CH691537A5 (es)
CZ (1) CZ292077B6 (es)
DE (7) DE20007303U1 (es)
DK (3) DK173903B1 (es)
EA (1) EA200200972A1 (es)
ES (3) ES2180471T3 (es)
FI (2) FI20010156A0 (es)
FR (1) FR2806086B1 (es)
GB (2) GB2357762B (es)
GR (1) GR1003796B (es)
HR (1) HRP20020756A2 (es)
HU (3) HU0001581D0 (es)
IE (1) IES20010109A2 (es)
IL (2) IL147339A (es)
IS (1) IS5841A (es)
IT (2) IT1319645B1 (es)
MX (1) MXPA02008793A (es)
NL (2) NL1016435C1 (es)
NO (2) NO312031B1 (es)
PL (1) PL360158A1 (es)
PT (2) PT1169314E (es)
SE (2) SE517136C2 (es)
SI (2) SI1169314T2 (es)
SK (1) SK285528B6 (es)
TR (1) TR200202185T2 (es)
UA (1) UA74360C2 (es)
WO (1) WO2001068627A1 (es)
YU (1) YU68802A (es)
ZA (1) ZA200207148B (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227473B1 (en) 1999-04-14 2011-07-28 Lundbeck & Co As H Method for preparation of citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
EP1345542B1 (en) 2000-12-20 2011-02-23 Fox Hollow Technologies, Inc. Debulking catheter
ES2228824T3 (es) * 2000-12-22 2005-04-16 H. Lundbeck A/S Metodo de preparacion de citalopram puro.
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
MXPA03008777A (es) * 2001-05-01 2004-02-12 Lundbeck & Co As H El uso de escitalopram enantiomericamente puro.
DK1522539T3 (da) 2001-07-31 2007-05-07 Lundbeck & Co As H Krystallinsk komposition indeholdende excitalopram
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
GB0204607D0 (en) 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB2387596B (en) * 2002-02-27 2004-02-11 Matrix Lab Ltd Process
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
WO2004094399A1 (en) * 2003-04-21 2004-11-04 Natco Pharma Ltd An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
GB0317475D0 (en) 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
AU2006261788B2 (en) 2005-06-27 2012-05-31 Valeant International Bermuda Modified-release formulations of a bupropion salt
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
CA2760449A1 (en) 2009-04-29 2010-11-04 Tyco Healthcare Group Lp Methods and devices for cutting and abrading tissue
WO2010132748A1 (en) 2009-05-14 2010-11-18 Fox Hollow Technologies, Inc. Easily cleaned atherectomy catheters and methods of use
RU2526915C2 (ru) 2009-12-02 2014-08-27 ТАЙКО ХЕЛСКЕА ГРУП эЛПи Способы и устройства для срезания ткани
KR20140006106A (ko) 2009-12-11 2014-01-15 코비디엔 엘피 물질 포획 효율이 향상된 물질 제거 장치 및 사용 방법
CA2800920C (en) 2010-06-14 2015-04-14 Covidien Lp Material removal device
CN103200886B (zh) 2010-10-28 2015-07-29 科维蒂恩有限合伙公司 物质移除装置和使用方法
EP2659840B1 (en) 2010-11-11 2017-02-01 Covidien LP Flexible debulking catheters with imaging
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143703A (es) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
CN1206207C (zh) * 1997-07-08 2005-06-15 H.隆德贝克有限公司 氰酞氟苯胺的制备方法
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
SK283907B6 (sk) * 1997-11-11 2004-04-06 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
HU227473B1 (en) 1999-04-14 2011-07-28 Lundbeck & Co As H Method for preparation of citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
ZA200207148B (en) 2003-04-23
DE60100786D1 (de) 2003-10-23
SK285528B6 (sk) 2007-03-01
DE60100786T2 (de) 2004-07-15
PL360158A1 (en) 2004-09-06
ITMI20002425A1 (it) 2002-05-09
YU68802A (sh) 2005-11-28
GR1003796B (el) 2002-02-08
SE517136C2 (sv) 2002-04-16
HUP0100531A2 (hu) 2002-01-28
MXPA02008793A (es) 2003-02-12
DE60100022T2 (de) 2003-03-06
CH691477A5 (de) 2001-07-31
CA2360287A1 (en) 2001-09-20
CN1429220A (zh) 2003-07-09
US20040132808A1 (en) 2004-07-08
IT1319645B1 (it) 2003-10-23
US20040167210A1 (en) 2004-08-26
WO2001068627A1 (en) 2001-09-20
FR2806086B1 (fr) 2003-05-09
HU0100450D0 (en) 2001-04-28
BG107065A (bg) 2003-05-30
DK173903B1 (da) 2002-02-11
FI20010225A0 (fi) 2001-02-07
DE1227088T1 (de) 2003-02-06
FI20010225L (fi) 2001-09-14
GB0102797D0 (en) 2001-03-21
FR2806086A1 (fr) 2001-09-14
ES2180471T3 (es) 2004-05-01
NO315851B1 (no) 2003-11-03
ITMI20010406A1 (it) 2002-08-28
IL147339A0 (en) 2002-08-14
NO20020356L (no) 2001-09-14
CH691537A5 (de) 2001-08-15
SE0200730L (sv) 2002-08-29
EP1169314A1 (en) 2002-01-09
GB2357762B (en) 2002-01-30
ES2173054T3 (es) 2002-12-16
SE0103046D0 (sv) 2001-09-14
SI1227088T1 (en) 2003-12-31
NO20010619L (no) 2001-09-14
HRP20020756A2 (en) 2004-12-31
NO20010619D0 (no) 2001-02-06
CN1258530C (zh) 2006-06-07
CZ292077B6 (cs) 2003-07-16
UA74360C2 (uk) 2005-12-15
US20050165092A1 (en) 2005-07-28
AU3725201A (en) 2001-09-13
ATE250050T1 (de) 2003-10-15
SE526022C2 (sv) 2005-06-14
DK1169314T3 (da) 2002-10-14
SI1169314T2 (sl) 2011-08-31
EP1169314B2 (en) 2011-06-01
DE10164687B4 (de) 2006-04-27
HU0100531D0 (en) 2001-03-28
EA200200972A1 (ru) 2003-02-27
EP1169314B1 (en) 2002-09-04
IES20010109A2 (en) 2002-02-20
DE20121240U1 (de) 2002-07-04
US20060247451A1 (en) 2006-11-02
CN1680350A (zh) 2005-10-12
IL158072A0 (en) 2004-03-28
NO20020356D0 (no) 2002-01-23
BR0109373A (pt) 2002-12-24
US20010031784A1 (en) 2001-10-18
GB2357762A (en) 2001-07-04
FI20010156A0 (fi) 2001-01-25
NO312031B1 (no) 2002-03-04
DE60100022T3 (de) 2011-11-17
SI1169314T1 (en) 2002-12-31
KR20020080486A (ko) 2002-10-23
AU2001100197A4 (en) 2001-09-20
ES2180471T1 (es) 2003-02-16
EP1227088A1 (en) 2002-07-31
HK1054750A1 (en) 2003-12-12
ES2173054T1 (es) 2002-10-16
SK13132002A3 (sk) 2003-01-09
AU746664B2 (en) 2002-05-02
TR200202185T2 (tr) 2002-12-23
US20030078442A1 (en) 2003-04-24
DE10108042A1 (de) 2001-10-18
CA2411732A1 (en) 2001-09-20
ES2159491A1 (es) 2001-10-01
JP2003527383A (ja) 2003-09-16
AU2001100197B4 (en) 2001-12-06
HUP0100531A3 (en) 2004-04-28
PT1169314E (pt) 2002-11-29
DE60100022D1 (de) 2002-10-10
IL147339A (en) 2004-09-27
SE0200730D0 (sv) 2002-03-12
AT4364U1 (de) 2001-06-25
ATE223396T1 (de) 2002-09-15
NL1016435C1 (nl) 2000-11-06
US20050165244A1 (en) 2005-07-28
GB0105982D0 (en) 2001-05-02
AR029811A1 (es) 2003-07-16
DK1227088T3 (da) 2003-12-22
SE0103046L (sv) 2001-11-14
FI109022B (fi) 2002-05-15
HU0001581D0 (en) 2000-06-28
PT1227088E (pt) 2003-12-31
CA2360287C (en) 2003-09-09
DE20007303U1 (de) 2000-07-27
BE1013210A3 (fr) 2001-10-02
CZ2001808A3 (cs) 2002-01-16
EP1227088B1 (en) 2003-09-17
NL1017413C1 (nl) 2001-09-13
IS5841A (is) 2001-09-14

Similar Documents

Publication Publication Date Title
ES2159491B1 (es) Base cristalina de citalopram
ES2195554T3 (es) Metodo para la preparacion de citalopram.
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
UY26886A1 (es) Polimorfos de un análogo de epotilona
UY28946A1 (es) Compuestos de aril-y heteroaril-alquilanina que contienen pirazol, composiciones farmacéuticas que contienen los compuestos y nuevos productos químicos intermedios
CR8859A (es) Derivados de piridina
ECSP066455A (es) Antagonistas del receptor de trombina
BR0310077A (pt) Novos compostos e sua utilização
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
DK1263730T3 (da) Aminderivater til behandling af apoptose
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
ES2158034T3 (es) Derivado de benzotiepina opticamente activo, su preparacion y uso.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
ECSP044973A (es) Nuevas formas polimorficas cristalinas de clorhidrato de lercanidipina y proceso para su preparacion
MX9200206A (es) 1,2,3,4- TETRAHIDROCICLOPENT (b) INDOLES SUSBSTITUIDOS, 1,2,3,3a-4,8a- HEXAHIDROCICLOPENT (b) INDOLES Y COMPUESTOS RELACIONADOS, COMPUESTOS INTERMEDIOS Y UN PROCEDIMIENTO PARA LA PREPARACIONDE LOS MISMOS Y SU USO COMO MEDICAMENTOS.
BR0214649A (pt) Derivados de aminotetralina como antagonistas do receptor muscarìnico
BR0109176A (pt) Método para preparação de citalopram e composto da fórmula
TR200708792T1 (tr) Kristal esitalopram bazı ve esitalopram içeren ağızda dağılan tabletler
SV2004001419A (es) Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal" ref.pc23005
BR0015877A (pt) Polimorfo v de torasemida
BRPI0409957A (pt) imidazolin-2-ilaminofenil amidas
DK1893589T3 (da) Substituerede N-benzo[d]isoxazol-3-yl-amin-derivater som inhibitorer af mGluR5-, serotonin-(5-HT) og noradrenalinreceptorer og deres anvendelse til fremstilling af lægemidler

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20160120

Kind code of ref document: A1

Effective date: 20160120

EC2A Search report published

Date of ref document: 20010120

Kind code of ref document: A1

Effective date: 20010120

FD1A Patent lapsed

Effective date: 20101018